Achillion (ACHN +4.6%) gains on a price target increase to $17 from $12 at Deutsche Bank. The...

|About: Achillion Pharmaceuticals, ... (ACHN)|By:, SA News Editor

Achillion (ACHN +4.6%) gains on a price target increase to $17 from $12 at Deutsche Bank. The firm says liver abstracts from Bristol-Myers (BMY +0.6%) and Abbott (ABT +0.1%) bode well for the future success of ACHN's two drug combo regimens for the treatment of hepatitus C virus. The firm made similar comments yesterday about Gilead (GILD +1.6%).